Aspen earnings rise as drug maker targets weight-loss market
Normalised earnings from continuing operations rose 28% at constant exchange rates in the year through June.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.moneyweb.co.za — the content belongs to Moneyweb.